Ontology highlight
ABSTRACT: Background
Knee osteoarthritis (KOA) is a major health problem especially in the aging population. There is a need for safe treatment that restores the cartilage and reduces the symptoms. The use of stem cells is emerging as a possible option for the moderate and severe cases. This study aimed at testing the safety of autologous bone marrow mesenchymal stem cells (BM-MSCs) expanded in vitro when given intra-articularly to patients with stage II and III KOA. As a secondary end point, the study tested the ability of these cells to relieve symptoms and restore the knee cartilage in these patients as judged by normalized knee injury and Osteoarthritis Outcome Score (KOOS) and by magnetic resonance imaging (MRI).Methods
Thirteen patients with a mean age of 50 years suffering fro
SUBMITTER: Al-Najar M
PROVIDER: S-EPMC5727956 | biostudies-literature | 2017 Dec
REPOSITORIES: biostudies-literature